The FDA has approved Skytrofa® (lonapegsomatropin-tcgd) for treating adults with growth hormone deficiency (GHD).This ...

Subcutaneous injections do not require a port like an IV, eliminating the risk for port-related complications such as infections.

What if you could inject a drug into a "problem area" – like abdominal fat – that could kill off fat cells and reduce fat ...

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.Nivolumab and ...

The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for the replacement of growth hormone in adults with GHD.

The opinion is based on positive data from the phase 3 Balance study, which showed a significant reduction of triglycerides ...

A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...

The subcutaneous route allows drugs such as insulin and heparin to be absorbed slowly over a period of time. Using the correct injection technique and selecting the correct site will minimise the risk ...

CHICAGO — An oral robotic pill may provide an alternative delivery method to subcutaneous injection for teriparatide and other biologics, according to a speaker at ENDO 2023. In findings from a ...

Ocrevus subcutaneous injection was non-inferior to Ocrevus IV infusion as measured by Ocrevus levels in the blood of patients (area under the serum concentration time curve) from day 1 to 12 weeks ...